US HIV physicians routinely offering early ART but only a third have prescribed PrEP
Recent infection and ART treatment interruptions are key periods for HIV transmission
New HCV NS5A inhibitor EDP-239 looks good in early studies, more evidence supports early hepatitis C treatment
PrEP preferences in gay men are predicted by the frequency and predictability of the sex they have
WHO guidelines recommend universal antiretroviral treatment, PrEP for those at substantial risk